123 related articles for article (PubMed ID: 15044749)
1. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study.
Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Tombach B
Radiology; 2004 May; 231(2):474-81. PubMed ID: 15044749
[TBL] [Abstract][Full Text] [Related]
2. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
[TBL] [Abstract][Full Text] [Related]
3. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
4. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A).
Reimer P; Allkemper T; Matuszewski L; Balzer T
J Magn Reson Imaging; 1999 Jul; 10(1):65-71. PubMed ID: 10398979
[TBL] [Abstract][Full Text] [Related]
6. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
[TBL] [Abstract][Full Text] [Related]
7. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.
Allkemper T; Bremer C; Matuszewski L; Ebert W; Reimer P
Radiology; 2002 May; 223(2):432-8. PubMed ID: 11997549
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
[TBL] [Abstract][Full Text] [Related]
10. Breath-hold 3D MR coronary angiography with a new intravascular contrast agent (feruglose)--first clinical experiences.
Sandstede JJ; Pabst T; Wacker C; Wiesmann F; Hoffmann V; Beer M; Kenn W; Bauer W; Hahn D
Magn Reson Imaging; 2001 Feb; 19(2):201-5. PubMed ID: 11358658
[TBL] [Abstract][Full Text] [Related]
11. Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent--experimental study in the rat.
Johansson L; Johnsson C; Penno E; Björnerud A; Ahlström H
Radiology; 2002 Oct; 225(1):97-103. PubMed ID: 12354991
[TBL] [Abstract][Full Text] [Related]
12. [MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
Simon G; Daldrup-Link H; von Vopelius-Feldt J; Wendland M; Fu Y; Schlegel J; Rummeny E
Rofo; 2006 Feb; 178(2):200-6. PubMed ID: 16435251
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
Kopp AF; Laniado M; Dammann F; Stern W; Grönewäller E; Balzer T; Schimpfky C; Claussen CD
Radiology; 1997 Sep; 204(3):749-56. PubMed ID: 9280254
[TBL] [Abstract][Full Text] [Related]
14. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
[TBL] [Abstract][Full Text] [Related]
15. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
16. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.
Li W; Tutton S; Vu AT; Pierchala L; Li BS; Lewis JM; Prasad PV; Edelman RR
J Magn Reson Imaging; 2005 Jan; 21(1):46-52. PubMed ID: 15611942
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
[TBL] [Abstract][Full Text] [Related]
18. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.
Reimer P; Müller M; Marx C; Wiedermann D; Muller R; Rummeny EJ; Ebert W; Shamsi K; Peters PE
Radiology; 1998 Dec; 209(3):831-6. PubMed ID: 9844683
[TBL] [Abstract][Full Text] [Related]
19. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
Bremer C; Allkemper T; Baermig J; Reimer P
J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
[TBL] [Abstract][Full Text] [Related]
20. Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.
Klein C; Schalla S; Schnackenburg B; Bornstedt A; Hoffmann V; Fleck E; Nagel E
J Magn Reson Imaging; 2003 Jun; 17(6):656-62. PubMed ID: 12766894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
